Literature DB >> 28314514

Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.

Huan-Huan Lu1, Ping Xue1, Yuan-Yuan Zhu2, Xiu-Lian Ju1, Xiao-Jiao Zheng1, Xun Zhang1, Ting Xiao1, Christophe Pannecouque3, Ting-Ting Li4, Shuang-Xi Gu5.   

Abstract

30 new analogues of diarylpyrimidines were synthesized for further structural modifications, involving not only the linker but also the wing α of DAPYs. The anti-HIV-1 activities of all target molecules were evaluated, and most of them exhibited potent anti-HIV-1 (WT) activities and low cytotoxicities. Among which, compound 4g showed excellent activities against WT HIV-1 with an EC50 value of 5.8nM and SI of up to 26,034. Another compound 4ab bearing a novel pyridinyl Wing α also displayed attractive activities. The structure-activity relationship (SAR) study was also summarized.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; Anti-HIV; Diarylpyrimidines; Nonnucleoside reverse transcriptase inhibitors; SAR

Mesh:

Substances:

Year:  2017        PMID: 28314514     DOI: 10.1016/j.bmc.2017.03.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.

Authors:  Genyan Liu; Wenjie Wang; Youlan Wan; Xiulian Ju; Shuangxi Gu
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.